SGMT Sagimet Biosciences Inc. - Series A Common Stock
$6,59
Kurs · Mai 20, 2026
Fundamentaldaten per Mai 12, 2026
52W-Spanne
$3–$11
42% of range
Analystenbewertung
BUY
18 analysts
Kursziel
$28
+332% upside
P/E (TTM)
-3.7
ROE
-42.3%
Nettogewinnmarge
—
SGMT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$6.59
Marktkapitalisierung
—
P/E (TTM)
-3.7
EPS (TTM)
$-1.58
Umsatz (TTM)
$2M
Dividendenrendite
—
ROE
-42.3%
Verschuldungsgrad
—
52W-Spanne
$3 – $11
SGMT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$2M
2023-12-31
→
2023-12-31
EPS
$-1.58
2022-12-31
→
2025-12-31
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
SGMT
Peer-Median
P/E (TTM)
-3.7
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
SGMT
Peer-Median
ROA
-36.9%
-33.2%
ROE
-42.3%
-62.6%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
SGMT
Peer-Median
Current Ratio (Liquiditätsgrad)
22.8
5.8
Quick Ratio
22.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
SGMT
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
SGMT
Peer-Median
SGMT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
18 Analysten
- Starker Kauf 6 33,3%
- Kauf 10 55,6%
- Halten 2 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-05-18
Median
$28.50
← Unter allen Zielen
$6.59
Tief
$8.00
Hoch
$49.00
Median-Ziel
$28.50
+332,5%
Mittelwert-Ziel
$28.50
+332,5%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.10%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.33 | $-0.38 | 0.05% |
| 31. Dezember 2025 | $-0.29 | $-0.41 | 0.12% |
| 30. September 2025 | $-0.40 | $-0.39 | -0.01% |
| 30. Juni 2025 | $-0.32 | $-0.52 | 0.20% |
| 31. März 2025 | $-0.56 | $-0.68 | 0.12% |
Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SGMT | — | -3.7 | — | — | -42.3% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| REPL | $752M | -3.2 | — | — | -55.1% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| MNPR | — | — | — | — | — | — |
| FBRX | $353M | -5.8 | 106.6% | -2555.2% | -86.9% | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | — |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | · | · | $2M | |
| R&D Expense | $39M | $38M | $20M | |
| SG&A Expense | $18M | $16M | $13M | |
| Operating Expenses | $57M | $54M | $33M | |
| Operating Income | $-57M | $-54M | $-31M | |
| Other Non-op | $6M | $9M | $3M | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-51M | $-46M | $-28M | |
| EPS (Basic) | $-1.58 | $-1.45 | $-2.66 | |
| EPS (Diluted) | $-1.58 | $-1.45 | $-2.66 | |
| Shares (Basic) | 32,345,525 | 31,350,725 | 10,460,335 | |
| Shares (Diluted) | 32,345,525 | 31,350,725 | 10,460,335 | |
| EBITDA | $-57M | $-54M | $-31M |
Bilanz 16
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $35M | $76M | $75M | |
| Short-term Investments | $78M | $75M | $20M | |
| Prepaid Expense | $3M | $2M | $2M | |
| Other Current Assets | $199.0K | $157.0K | $74.0K | |
| Current Assets | $116M | $153M | $97M | |
| Total Assets | $116M | $160M | $97M | |
| Accounts Payable | $1M | $1M | $186.0K | |
| Accrued Liabilities | $4M | $3M | $5M | |
| Current Liabilities | $5M | $4M | $6M | |
| Total Liabilities | · | $4M | $6M | |
| Paid-in Capital | $458M | $451M | $341M | |
| Retained Earnings | $-346M | $-295M | $-250M | |
| AOCI | $120.0K | $230.0K | $30.0K | |
| Stockholders' Equity | $111M | $156M | $91M | |
| Liabilities + Equity | $116M | $160M | $97M | |
| Shares Outstanding | · | · | 0 |
Cashflow 6
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $5M | |
| Operating Cash Flow | $-46M | $-42M | $-24M | |
| Investing Cash Flow | $5M | $-62M | $13M | |
| Stock Issued | $0 | $106M | · | |
| Net Stock Activity | $0 | $106M | · | |
| Financing Cash Flow | $275.0K | $105M | $86M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | · | -1537.0% | |
| Net Margin | · | · | -1393.8% | |
| EBITDA Margin | · | · | -1537.0% | |
| ROA | -36.9% | -35.5% | -43.0% | |
| ROE | -42.3% | -27.9% | -29.5% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 22.8 | 34.3 | 17.1 | |
| Quick Ratio | 22.2 | 34.0 | 16.8 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | · | · | $2M | |
| Net Income TTM | $-51M | $-46M | $-28M | |
| Market Cap | · | · | $0 | |
| P/E | -3.7 | -3.1 | -2.0 | |
| P/S | · | · | 0.0 | |
| P / Tangible Book | · | · | 0.0 | |
| P / Cash Flow | · | · | 0.0 | |
| Earnings Yield | -26.7% | -32.2% | -49.1% |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | $0 | $2M | |
| R&D Expense | $7M | $7M | $10M | $7M | $15M | $14M | $13M | $6M | $5M | $6M | $5M | |
| SG&A Expense | $5M | $4M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $12M | $11M | $14M | $12M | $20M | $18M | $17M | $11M | $9M | $9M | $9M | |
| Operating Income | $-12M | $-11M | $-14M | $-12M | $-20M | $-18M | $-17M | $-11M | $-9M | $-9M | $-7M | |
| Other Non-op | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Net Income | $-11M | $-10M | $-13M | $-10M | $-18M | $-16M | $-15M | $-8M | $-7M | $-8M | $-6M | |
| EPS (Basic) | $-0.33 | $-0.30 | $-0.40 | $-0.32 | $-0.56 | $-0.52 | $-0.45 | $-0.25 | $-0.23 | $69.07 | $-0.35 | |
| EPS (Diluted) | $-0.33 | $-0.30 | $-0.40 | $-0.32 | $-0.56 | $-0.52 | $-0.45 | $-0.25 | $-0.23 | $69.07 | $-0.35 | |
| Shares (Basic) | 32,559,704 | -64,510,079 | 32,464,893 | 32,195,366 | 32,195,345 | -61,745,925 | 32,143,336 | 31,913,887 | 29,039,427 | -8,109,004 | 18,194,682 | |
| Shares (Diluted) | 32,559,704 | -64,510,079 | 32,464,893 | 32,195,366 | 32,195,345 | -61,745,925 | 32,143,336 | 31,913,887 | 29,039,427 | -8,109,004 | 18,194,682 | |
| EBITDA | $-12M | · | $-14M | $-12M | $-20M | · | $-17M | $-11M | $-9M | · | $-7M |
Bilanz 17
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $35M | $32M | $42M | $65M | $76M | $77M | $96M | $177M | $75M | $102M | |
| Short-term Investments | $68M | $78M | $84M | $83M | $80M | $75M | $75M | $70M | $17M | $20M | $0 | |
| Prepaid Expense | $3M | $3M | $3M | $2M | $2M | $2M | $5M | $378.0K | $786.0K | $2M | $974.0K | |
| Other Current Assets | $248.0K | $199.0K | $253.0K | $173.0K | $263.0K | $157.0K | $101.0K | $130.0K | $108.0K | $74.0K | $77.0K | |
| Current Assets | $108M | $116M | $119M | $127M | $146M | $153M | $157M | $167M | $194M | $97M | $103M | |
| Other Non-current Assets | · | · | · | · | $62.0K | · | · | · | · | · | · | |
| Total Assets | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M | $195M | $97M | $103M | |
| Accounts Payable | $2M | $1M | $4M | $2M | $3M | $1M | $1M | $2M | $531.0K | $186.0K | $2M | |
| Accrued Liabilities | $3M | $4M | $5M | $5M | $4M | $3M | $3M | $4M | $4M | $5M | $3M | |
| Current Liabilities | $5M | $5M | $9M | $7M | · | $4M | · | · | · | $6M | $5M | |
| Total Liabilities | · | · | · | · | $7M | · | $4M | $6M | $5M | · | $5M | |
| Paid-in Capital | $459M | $458M | $456M | $454M | $452M | $451M | $449M | $448M | $446M | $341M | $339M | |
| Retained Earnings | $-357M | $-346M | $-337M | $-324M | $-313M | $-295M | $-279M | $-264M | $-256M | $-250M | $-242M | |
| AOCI | $8.0K | $120.0K | $117.0K | $76.0K | $121.0K | $230.0K | $441.0K | $-23.0K | $7.0K | $30.0K | · | |
| Stockholders' Equity | $102M | $111M | $119M | $130M | $139M | $156M | $171M | $183M | $190M | $91M | $98M | |
| Liabilities + Equity | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M | $195M | $97M | $103M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | 0 | 0 |
Cashflow 6
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $759.0K | $1M | $2M | |
| Operating Cash Flow | $-9M | $-12M | $-10M | $-9M | $-15M | $-11M | $-20M | $-6M | $-6M | $-7M | $-4M | |
| Investing Cash Flow | $10M | $14M | $75.0K | $-13M | $3M | $10M | $624.0K | $-75M | $3M | $-20M | $0 | |
| Stock Issued | · | $0 | $0 | · | · | $0 | $0 | $0 | $106M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $106M | · | · | |
| Financing Cash Flow | · | $0 | $274.0K | · | · | $0 | $0 | $-27.0K | $105M | $0 | $87M |
Rentabilität 5
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -372.6% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -317.6% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -372.6% | |
| ROA | -8.4% | · | -8.5% | -6.4% | -10.7% | · | -10.5% | -7.7% | -6.8% | · | -12.3% | |
| ROE | -8.8% | · | -8.9% | -6.6% | -11.1% | · | -10.9% | 107.4% | -7.0% | · | -13.0% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.3 | · | 13.1 | 17.6 | · | · | · | · | · | · | 20.4 | |
| Quick Ratio | 19.7 | · | 12.8 | 17.3 | · | · | · | · | · | · | 20.2 |
Effizienz 1
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 |
Bewertung (TTM) 5
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-52M | · | $-56M | $-51M | $-48M | · | $-36M | $-28M | $-26M | · | $-27M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | $0 | |
| P/E | -3.2 | · | -4.0 | -4.8 | -2.2 | · | -2.2 | -0.1 | -0.1 | · | -0.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Earnings Yield | -30.8% | · | -25.2% | -20.7% | -45.7% | · | -46.2% | -1071.0% | -1327.7% | · | -1273.5% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Umsatz | — | — | $2M | — |
| Betriebsgewinnmarge % | — | — | -1537.0% | — |
| Nettoergebnis | $-51M | $-46M | $-28M | $-30M |
| Verwässerte EPS | $-1.58 | $-1.45 | $-2.66 | $-165.20 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Liquiditätsgrad | 22.8 | 34.3 | 17.1 | — |
| Quick Ratio | 22.2 | 34.0 | 16.8 | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.